Literature DB >> 9502184

Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group.

J Vakkilainen1, K V Porkka, I Nuotio, P Pajukanta, L Suurinkeroinen, K Ylitalo, J S Viikari, C Ehnholm, M R Taskinen.   

Abstract

BACKGROUND: Familial combined hyperlipidaemia (FCHL) is a common hereditary disorder. Hypertriglyceridaemia is associated with glucose intolerance and insulin resistance.
METHODS: To study glucose tolerance in FCHL patients with different lipid phenotypes [hypercholesterolaemia (IIA), mixed hyperlipidaemia (IIB), hypertriglyceridaemia (IV)], we investigated 253 family members and 92 spouses arising from 33 well-defined Finnish FCHL pedigrees.
RESULTS: In oral glucose tolerance tests the affected family members had higher values for glucose area under the curve than did non-affected family members [673+/-127 min mmolL(-1), 754+/-145 min mmol L(-1), 846+/-180 min mmol L(-1) and 838+/-183 min mmol L(-1) for phenotypes normal, IIA, IIB and IV respectively; P < 0.001 after adjustment for body mass index, waist circumference and age]. Impaired glucose tolerance and diabetes were more common among affected than non-affected family members (prevalences of normal glucose tolerance 94.0%, 80.0%, 54.3% and 58.5% for phenotypes normal, IIA, IIB and IV).
CONCLUSION: Affected FCHL family members were more glucose intolerant than non-affected family members. In men, this disturbance was not related to lipid phenotype nor was it explained by obesity.

Entities:  

Mesh:

Year:  1998        PMID: 9502184     DOI: 10.1046/j.1365-2362.1998.00243.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

Review 2.  Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Authors:  Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.

Authors:  P Pajukanta; J D Terwilliger; M Perola; T Hiekkalinna; I Nuotio; P Ellonen; M Parkkonen; J Hartiala; K Ylitalo; J Pihlajamäki; K Porkka; M Laakso; J Viikari; C Ehnholm; M R Taskinen; L Peltonen
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

4.  A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

Authors:  B E Aouizerat; H Allayee; R M Cantor; R C Davis; C D Lanning; P Z Wen; G M Dallinga-Thie; T W de Bruin; J I Rotter; A J Lusis
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

5.  TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia.

Authors:  A Huertas-Vazquez; C Plaisier; D Weissglas-Volkov; J Sinsheimer; S Canizales-Quinteros; I Cruz-Bautista; E Nikkola; M Herrera-Hernandez; A Davila-Cervantes; T Tusie-Luna; M-R Taskinen; C Aguilar-Salinas; P Pajukanta
Journal:  Diabetologia       Date:  2007-10-31       Impact factor: 10.122

Review 6.  Genetics of familial combined hyperlipidemia.

Authors:  P Pajukanta; K V Porkka
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.